Cargando…

Causes of Death and Conditional Survival of Renal Cell Carcinoma

Background: As conditional survival could provide more relevant prognostic information at each follow-up time, the present study aimed to assess conditional overall survival (COS) based on two cohorts and assess the risks of death due to renal cell carcinoma (RCC) vs. other causes. Methods: The Fuda...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Ning, Wan, Fangning, Abudurexiti, Mierxiati, Wang, Jun, Zhu, Yao, Ye, Dingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644417/ https://www.ncbi.nlm.nih.gov/pubmed/31380266 http://dx.doi.org/10.3389/fonc.2019.00591

Ejemplares similares

Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab
por: Shao, Ning, et al.
Publicado: (2019)

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
por: Abudurexiti, MierXiati, et al.
Publicado: (2019)

Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
por: Xu, Peihang, et al.
Publicado: (2020)

Prognosis of rare pathological primary urethral carcinoma
por: Abudurexiti, Mierxiati, et al.
Publicado: (2018)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Conditional disease-free survival in high-risk renal cell carcinoma treated with sunitinib
por: Shao, Ning, et al.
Publicado: (2019)

m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Locoregional surgical treatment improves the prognosis in patients with primary metastatic testicular cancer with a single bone or brain metastasis
por: Abudurexiti, Mierxiati, et al.
Publicado: (2020)

Fat Attenuation Index of Renal Cell Carcinoma Reveals Biological Characteristics and Survival Outcome
por: Wang, Hongkai, et al.
Publicado: (2022)

Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2018)

Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma
por: Wang, Beihe, et al.
Publicado: (2019)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma
por: Fangning, Wan, et al.
Publicado: (2017)

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma
por: Zhang, Guiming, et al.
Publicado: (2015)

A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer
por: Shao, Ning, et al.
Publicado: (2020)

Cause of Death During Renal Cell Carcinoma Survivorship: A Contemporary, Population-Based Analysis
por: Yu, Dong-Dong, et al.
Publicado: (2022)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Development and validation of lncRNAs-based nomogram for prediction of biochemical recurrence in prostate cancer by bioinformatics analysis
por: Shao, Ning, et al.
Publicado: (2019)

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma
por: Xiao, Wen-jun, et al.
Publicado: (2019)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
por: Li, Shuaishuai, et al.
Publicado: (2022)

Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma
por: Yu, Deshui, et al.
Publicado: (2022)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)

A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Su, Jiaqi, et al.
Publicado: (2022)

Clinical Outcomes and Prognosis Analysis of Younger Bladder Cancer Patients
por: Abudurexiti, Mierxiati, et al.
Publicado: (2022)

Cause of death during nasopharyngeal carcinoma survivorship: a population-based analysis
por: Zhou, Jie, et al.
Publicado: (2023)

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma
por: Wu, Kan, et al.
Publicado: (2020)

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma
por: Chang, Kun, et al.
Publicado: (2022)

Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell Carcinoma
por: Yan, Lei, et al.
Publicado: (2021)

A Nomogram Predicting the Progression-Free Survival of Nonmetastatic Renal Cell Carcinoma Patients With Venous Thrombus After Surgery
por: Zhang, Yu, et al.
Publicado: (2022)

Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
por: Jia, Keren, et al.
Publicado: (2019)

PAQR5 Expression Is Suppressed by TGFβ1 and Associated With a Poor Survival Outcome in Renal Clear Cell Carcinoma
por: Tao, Chang, et al.
Publicado: (2022)

NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer
por: Wu, Junlong, et al.
Publicado: (2017)

An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
por: Wang, Licheng, et al.
Publicado: (2023)

Clinicopathological characteristics and loss of mismatch repair protein expression in Chinese upper tract urothelial carcinomas
por: Shang, Zhi, et al.
Publicado: (2022)

Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis
por: Peng, Fu-Sheng, et al.
Publicado: (2022)

Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma
por: Yao, Jia xi, et al.
Publicado: (2020)

Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma
por: Barkan, Ella, et al.
Publicado: (2023)

Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma
por: Bourlon, Maria T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5bme7prr7st68vjfc1lppqp9hv